Related Experiment Video
Updated: Jul 1, 2026

14:45
Technical Detail for Robot Assisted Pancreaticoduodenectomy
Published on: September 28, 2019
14.6K
Striated Duct Adenoma: A Case Report and a Scoping Review
Roberta Rayra Martins-Chaves1,2, Maria Clara Martins Avelar3, Artur Luiz Dias Ferreira3
1Faculty of Medical Sciences of Minas Gerais, Alameda Ezequiel Dias, 275, Belo Horizonte, MG, Brazil. roberta.chaves@cienciasmedicasmg.edu.br.
Head and Neck Pathology
|September 30, 2024
Summary
Striated duct adenoma (SDA) is a rare salivary gland tumor. Immunohistochemistry for IDH1/2 mutations aids in its diagnosis, distinguishing it from similar conditions.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- Striated duct adenoma (SDA) is a rare benign salivary gland tumor.
- SDA possesses a distinct genetic signature involving IDH2 gene mutations.
- These mutations differentiate SDA from canalicular adenoma, its main differential diagnosis.
Purpose of the Study:
- To report a case of parotid gland SDA with IDH1/2 mutation-specific immunohistochemistry.
- To conduct a scoping review synthesizing all previously published SDA cases.
- To analyze the clinicopathological features and outcomes of SDA.
Main Methods:
- Case report of SDA with immunohistochemical analysis for IDH1/2 mutations.
- Scoping review following Cochrane Methodology and JBI checklist.
- Systematic literature search across Medline, Embase, Web of Science, and LILACS without date or language restrictions.
Main Results:
- Seven studies comprising 20 SDA patients (including the reported case) were analyzed.
- SDA predominantly affects the parotid gland (13/20) in individuals aged ~62 years, with no sex predilection.
- Swelling was the primary clinical symptom; mean follow-up of 26 months showed no recurrence or metastasis post-resection.
Conclusions:
- Clinicopathological awareness and IDH1/2 mutation-specific immunohistochemistry are crucial for accurate SDA identification.
- Further follow-up is necessary to fully understand the biological potential of SDA.
- Consistent identification is key for appropriate patient management and prognosis.

